These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 11647760)
1. Drug firm was aware of deaths, probe says. Mintz M Washington Post; 1982 Dec; ():A2. PubMed ID: 11647760 [No Abstract] [Full Text] [Related]
2. Firm allegedly sold vitamin after it learned of deaths. Russell C Washington Post; 1984 May; ():A1, A19. PubMed ID: 11646393 [No Abstract] [Full Text] [Related]
4. International research agreement leads to new U.S. guidelines. Maloney DM Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182 [No Abstract] [Full Text] [Related]
5. Data audit by a regulatory agency: its effect and implication for others. Shapiro MF Account Res; 1992; 2(3):219-29. PubMed ID: 11653981 [No Abstract] [Full Text] [Related]
6. Bioethics and applied biomaterials. Saha S; Saha P J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924 [No Abstract] [Full Text] [Related]
7. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators. Nightingale SL Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914 [No Abstract] [Full Text] [Related]
8. The informed-consent policy of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use: knowledge is the best medicine. Miller MD Cornell Int Law J; 1997; 30(1):203-44. PubMed ID: 11660583 [No Abstract] [Full Text] [Related]
9. Harm to research subjects will now lead to new federal regulations. Maloney DM Hum Res Rep; 1994 Dec; 9(12):1-3. PubMed ID: 11654161 [No Abstract] [Full Text] [Related]
10. RU 486 and the politics of drug regulation in the United States and France. Kramnick RK Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340 [No Abstract] [Full Text] [Related]
11. A look at the bioresearch monitoring program: the agency perspective. Brisson EL Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578 [No Abstract] [Full Text] [Related]
12. New rules for new drugs: the challenge of AIDS to the regulatory process. Edgar H; Rothman DJ Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413 [TBL] [Abstract][Full Text] [Related]
13. Regulation of genetic modification of organisms: science or emotion? Malinowski MJ J Biolaw Bus; 1998; 1(3):3-7. PubMed ID: 11657280 [No Abstract] [Full Text] [Related]
14. US drug regulation: Congress finds FDA wanting. Budiansky S Nature; 1982 Aug; 298(5875):597-8. PubMed ID: 11643777 [TBL] [Abstract][Full Text] [Related]
15. Regulatory concerns regarding AIDS vaccine development. Sawyer LA; Katzenstein DA; Quinnan GV AIDS Public Policy J; 1988; 3(3):36-45. PubMed ID: 11650100 [No Abstract] [Full Text] [Related]
16. Super athletes made to order. Taylor WN Psychol Today; 1985 May; 19(5):62-6. PubMed ID: 11658564 [No Abstract] [Full Text] [Related]
17. The war on cancer: first do no harm. Part 2: Risk, rivalry and research--and error. Neumann J; Gup T Washington Post; 1981 Oct; ():A1, A26, A27. PubMed ID: 11646112 [No Abstract] [Full Text] [Related]
18. Money is putting people at risk in biomedical research. Andrews LB Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699 [No Abstract] [Full Text] [Related]
20. Trial of experimental AIDS drug to be continued, with revisions. Kolata G N Y Times Web; 1990 Mar; ():A1, A15. PubMed ID: 11646750 [No Abstract] [Full Text] [Related] [Next] [New Search]